Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136240175> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W3136240175 abstract "Abstract IPR, Biosafety and Bioethics covers a broad coverage of three areas of patenting--intellectual property rights (IPR), biosafety and bioethics. Intellectual Property Rights are the rights given to persons over the creations of their minds. Types of Intellectual property rights (IPR) such as copyright, patent, trademarks, industrial designs, trade secrets, geographical indications and so on are meant to protect creators of new inventions, their families and consumers. Strong IP rights help consumers make an educated choice about the safety, reliability, and effectiveness of their purchases. Enforced IP rights ensure that products are authentic, and of the high-quality that consumers recognize and accept. Biosafety is meant to create an appropriate bio safe working environment to protect workers from laboratory-induced infections who work with deadly disease-causing microorganisms such as the present pandemic Covid -19 virus, for their characterization, diagnostics or therapeutics and vaccine development purposes which are posing increasingly potential biosafety problems for healthcare personnel and laboratory workers. Bioethics is the typically controversial ethical issues emerging from new situations and possibilities brought about by advances in biology and medicine. Regulatory Frame Work : India is home to about 10,500 manufacturing units and over 3,000 pharma companies. India exports all forms of pharmaceuticals from APIs to formulations, both in modern medicine and traditional Indian medicines. The growth of pharmaceutical market depends upon various factors including regulatory legislations and drug regulatory system. Two major government agencies responsible for drug regulation and control are: 1) the Drugs Controller of India (DCI), and 2) the State Food and Drug Administrations (FDAs). The DCI, under the Ministry of Health, has five main functions: 1) Controlling the quality of imported drugs, 2) Coordinating the activities of State FDAs, 3) Enforcing new drug legislation, 4) Granting approval to new drugs, and 5) Controlling the quality of imported drugs. The present paper highlights IPR and some of the risks & regulations of biosafety for pharma industries" @default.
- W3136240175 created "2021-03-29" @default.
- W3136240175 creator A5044680650 @default.
- W3136240175 date "2020-01-01" @default.
- W3136240175 modified "2023-09-26" @default.
- W3136240175 title "IPR , BOISAFETY AND REGULATORY FRAME WORK FOR PHARMA INDUSTRIES" @default.
- W3136240175 hasPublicationYear "2020" @default.
- W3136240175 type Work @default.
- W3136240175 sameAs 3136240175 @default.
- W3136240175 citedByCount "0" @default.
- W3136240175 crossrefType "journal-article" @default.
- W3136240175 hasAuthorship W3136240175A5044680650 @default.
- W3136240175 hasConcept C108713360 @default.
- W3136240175 hasConcept C127413603 @default.
- W3136240175 hasConcept C138885662 @default.
- W3136240175 hasConcept C144133560 @default.
- W3136240175 hasConcept C150903083 @default.
- W3136240175 hasConcept C162853370 @default.
- W3136240175 hasConcept C17744445 @default.
- W3136240175 hasConcept C18762648 @default.
- W3136240175 hasConcept C188084074 @default.
- W3136240175 hasConcept C199539241 @default.
- W3136240175 hasConcept C2778137410 @default.
- W3136240175 hasConcept C2779709869 @default.
- W3136240175 hasConcept C34974158 @default.
- W3136240175 hasConcept C41895202 @default.
- W3136240175 hasConcept C52384281 @default.
- W3136240175 hasConcept C78519656 @default.
- W3136240175 hasConcept C86803240 @default.
- W3136240175 hasConceptScore W3136240175C108713360 @default.
- W3136240175 hasConceptScore W3136240175C127413603 @default.
- W3136240175 hasConceptScore W3136240175C138885662 @default.
- W3136240175 hasConceptScore W3136240175C144133560 @default.
- W3136240175 hasConceptScore W3136240175C150903083 @default.
- W3136240175 hasConceptScore W3136240175C162853370 @default.
- W3136240175 hasConceptScore W3136240175C17744445 @default.
- W3136240175 hasConceptScore W3136240175C18762648 @default.
- W3136240175 hasConceptScore W3136240175C188084074 @default.
- W3136240175 hasConceptScore W3136240175C199539241 @default.
- W3136240175 hasConceptScore W3136240175C2778137410 @default.
- W3136240175 hasConceptScore W3136240175C2779709869 @default.
- W3136240175 hasConceptScore W3136240175C34974158 @default.
- W3136240175 hasConceptScore W3136240175C41895202 @default.
- W3136240175 hasConceptScore W3136240175C52384281 @default.
- W3136240175 hasConceptScore W3136240175C78519656 @default.
- W3136240175 hasConceptScore W3136240175C86803240 @default.
- W3136240175 hasLocation W31362401751 @default.
- W3136240175 hasOpenAccess W3136240175 @default.
- W3136240175 hasPrimaryLocation W31362401751 @default.
- W3136240175 hasRelatedWork W1819430235 @default.
- W3136240175 hasRelatedWork W187968587 @default.
- W3136240175 hasRelatedWork W191587705 @default.
- W3136240175 hasRelatedWork W1976739527 @default.
- W3136240175 hasRelatedWork W2063965424 @default.
- W3136240175 hasRelatedWork W2075357821 @default.
- W3136240175 hasRelatedWork W2131107951 @default.
- W3136240175 hasRelatedWork W2417228291 @default.
- W3136240175 hasRelatedWork W2497452311 @default.
- W3136240175 hasRelatedWork W2528053971 @default.
- W3136240175 hasRelatedWork W2553857022 @default.
- W3136240175 hasRelatedWork W2563185047 @default.
- W3136240175 hasRelatedWork W2621826230 @default.
- W3136240175 hasRelatedWork W2767214709 @default.
- W3136240175 hasRelatedWork W2972251310 @default.
- W3136240175 hasRelatedWork W3124404402 @default.
- W3136240175 hasRelatedWork W3133060100 @default.
- W3136240175 hasRelatedWork W3167742373 @default.
- W3136240175 hasRelatedWork W3211592293 @default.
- W3136240175 hasRelatedWork W2186974635 @default.
- W3136240175 isParatext "false" @default.
- W3136240175 isRetracted "false" @default.
- W3136240175 magId "3136240175" @default.
- W3136240175 workType "article" @default.